Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Feb 14, 2022

BUY
$4.99 - $7.46 $998 - $1,492
200 Added 0.8%
25,200 $126,000
Q3 2021

Nov 15, 2021

SELL
$7.16 - $9.69 $179,000 - $242,250
-25,000 Reduced 50.0%
25,000 $179,000
Q2 2021

Aug 16, 2021

BUY
$6.23 - $10.03 $311,500 - $501,499
50,000 New
50,000 $464,000
Q3 2020

Nov 13, 2020

SELL
$9.57 - $27.05 $155,991 - $440,915
-16,300 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$7.14 - $31.69 $116,382 - $516,547
16,300 New
16,300 $439,000

Others Institutions Holding INO

About INOVIO PHARMACEUTICALS, INC.


  • Ticker INO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,400,000
  • Market Cap $1.06B
  • Description
  • Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...
More about INO
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.